CELH
Celsius Holdings, Inc.
CELH has the edge over COKE overall, supported by stronger valuation and stronger fundamentals.
COKE
Coca-Cola Consolidated, Inc.
COKE has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
COKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
COKE's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over COKE in the historical PE scenario, which offers more potential upside but is not a forecast.
COKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $126 | -39% |
| Fair | 21x | $176 | -15% |
| Current | 24x | $207 | — |
| Expensive | 26x | $224 | +8.4% |
Historical ranges are pointers, not guarantees.
COKE's PE is in its expensive range at 24x.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
COKE Forward outlook
There aren't enough analyst estimates for COKE to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
COKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.53 | +21% |
| Q2 2026 | $7.53 | +12% |
| Q1 2026 | $7.30 | +14% |
| Q4 2025 | $6.82 | +0.1% |
| Q3 2025 | $7.03 | +26% |
| Q2 2025 | $6.71 | +28% |
| Q1 2025 | $6.41 | +37% |
| Q4 2024 | $6.81 | +57% |
COKE has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over COKE on profitability, with a higher operating margin.
COKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +5.4% |
| Q2 2026 | $2.1B | +11% |
| Q1 2026 | $1.8B | +17% |
| Q4 2025 | $1.9B | +9% |
| Q3 2025 | $1.9B | +6.9% |
| Q2 2025 | $1.9B | +3.3% |
| Q1 2025 | $1.6B | -0.7% |
| Q4 2024 | $1.7B | +7.1% |
COKE's revenue has grown year over year for six quarters in a row: $2B last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +0.6 points |
| Q2 2026 | 13% | -1.4 points |
| Q1 2026 | 13% | +0.8 points |
| Q4 2025 | 13% | +0.4 points |
| Q3 2025 | 13% | +0.2 points |
| Q2 2025 | 15% | +0.2 points |
| Q1 2025 | 12% | -1.5 points |
| Q4 2024 | 13% | +1.6 points |
COKE's operating margin was 14% last quarter, up 0.6 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
COKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $172.2M | -35% |
| Q2 2026 | $131.1M | -12% |
| Q1 2026 | $142.2M | +42% |
| Q4 2025 | $107.3M | +27% |
| Q3 2025 | $264.1M | +85% |
| Q2 2025 | $148.5M | -7.5% |
| Q1 2025 | $100.3M | -14% |
| Q4 2024 | $84.8M | +135% |
COKE has the edge over CELH on cash flow, with stronger typical year-over-year growth.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
COKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -84.7K shares |
| 1 year | -23% | -20.2M shares |
| 3 years | -29% | -27.4M shares |
| 5 years | -29% | -27.5M shares |
| Available history | -29% | -27.6M shares |
COKE has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $28M |
| Q1 2026 | — |
| Q4 2025 | $2.5B |
| Q3 2025 | $111.3M |
| Q2 2025 | $34.4M |
| Q1 2025 | — |
| Q4 2024 | $51.6M |
COKE spent $2.5B buying back its own shares over the past year, more than ten times what it spent the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over COKE on leverage, with a lower net debt burden relative to earnings.
COKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.8x | Very low |
COKE's net debt is about 1.8 years of its operating earnings (EBITDA), up from less than a year a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
COKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 75.8 | Neutral |
COKE's weekly RSI is 60 (neutral) and its Stochastic is 76 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
COKE PE vs Consumer Defensive Sector
| Metric | COKE | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 19x | 25% above |
| PE % | 70 | 18 | 52 pts above |
COKE has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
COKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.2 | 2.4% above |
| 20 week MA | $194.5 | 6.4% above |
| 50 week MA | $184.6 | 12% above |
| 100 week MA | $155.5 | 33% above |
| 200 week MA | $120.3 | 72% above |
COKE has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
COKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.4 | $26.6 | -9.4% |
| 2021 | $26.6 | $59.4 | +123% |
| 2022 | $59.4 | $52.3 | -12% |
| 2023 | $52.3 | $92.8 | +78% |
| 2024 | $92.8 | $123.2 | +33% |
| 2025 | $123.2 | $160.6 | +30% |
| 2026 YTD | $160.6 | $207.0 | +29% |
COKE has the edge over CELH on returns for 2026, with the stronger performance.